Comprehensive study of co-processed excipients F- Melts®: Flow, viscoelastic and compacts properties

4. February 2021

This article aims to compare three commercially available co-processed excipients (CPEs), namely the F-Melts® type C,M and F1. All three...

graphical abstract of Development and statistical optimization of alginate-Neusilin US2 micro-composite beads to elicit gastric stability and sustained action of hesperidin

Development and statistical optimization of alginate-Neusilin US2 micro-composite beads to elicit gastric stability and sustained action of hesperidin

12. January 2021

The Alginate-Neusilin US2 micro-composite (MC) beads were fabricated and optimized for oral delivery of hesperidin (HES). A 32 full factorial design...

Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: In-vitro optimization/in-vivo evaluation

6. January 2021

Diacerein (DCN), a potent anti-inflammatory API used to treat osteoarthritis yet, it suffers from poor water solubility which affects its...

Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2

3. December 2020

Objective(s): Liqui-Mass technology has shown promising advantages in terms of commercial production and formulation manipulation. This study attempts to further...

Comparison of contact angle between conventional tablet and liquisolid compact

Liquisolid tablets – A rationale for formulation and process design

1. November 2020

A significant proportion of new API’s in development are poorly soluble and require alternative formulation approaches to achieve adequate oral...

Co-administration of mini-tablets orlistat and xanthan gum

Anti-obesity effect with reduced adverse effect of the co-administration of mini-tablets containing orlistat and mini-tablets containing xanthan gum: In vitro and in vivo evaluation

28. October 2020

The purpose of this study was to develop an oral dosage form of orlistat for the treatment of obesity with...

SMEDDS And Liquisolid Compacts To Simultaneously Improve The Solubility And Processability of Hydrochlorthiazide

27. October 2020

Hydrochlorothiazide (HCTZ) is a class IV BCS drug that exhibits varying bioavailability due to poor solubility and low permeability. The...

Comprehensive study of co-processed excipient F- Melt®: Flow, viscoelastic and compacts properties

15. October 2020

This article aims to compare three commercially available co-processed excipients (CPEs), namely the F-Melt® type C, M and F1. All...

A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics

11. October 2020

Efficacious oral delivery of therapeutic proteins remains challenging and nanoparticulate approaches are gaining interest for enhancing their permeability. In this...

Overcoming Pharmaceutical Formulation Challenges – Fuji Chemical Webinars

29. September 2020

7 October 2020 & 13 October 2020 – both 12:00 PM EST, 9:00 AM PST Using Speciality Excipients from Fuji...

Fuji Chemical